Menu
Search
|

Menu

Close
X

ICAD Inc ICAD.OQ (NASDAQ Stock Exchange Capital Market)

6.79 USD
+0.09 (+1.34%)
As of Jul 23
Previous Close 6.70
Open 6.71
Volume 11,183
3m Avg Volume 33,822
Today’s High 6.89
Today’s Low 6.57
52 Week High 7.22
52 Week Low 2.50
Shares Outstanding (mil) 16.59
Market Capitalization (mil) 76.17
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY19
7
FY18
26
FY17
28
FY16
26
EPS (USD)
FY19
-0.216
FY18
-0.540
FY17
0.289
FY16
-0.633
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.67
Price to Sales (TTM)
vs sector
2.91
7.92
Price to Book (MRQ)
vs sector
3.08
5.39
Price to Cash Flow (TTM)
vs sector
--
24.37
Total Debt to Equity (MRQ)
vs sector
0.00
14.56
LT Debt to Equity (MRQ)
vs sector
0.00
10.21
Return on Investment (TTM)
vs sector
-32.50
14.49
Return on Equity (TTM)
vs sector
-33.49
15.79

EXECUTIVE LEADERSHIP

Michael Klein
Executive Chairman of the Board, Chief Executive Officer, Since 2018
Salary: --
Bonus: --
Stacey Stevens
President, Since 2019
Salary: $270,000.00
Bonus: --
R. Scott Areglado
Chief Financial Officer, Vice President, Controller, Since 2019
Salary: --
Bonus: --
Jonathan Go
Chief Technology Officer, Since 2019
Salary: $255,000.00
Bonus: --
Rakesh Patel
Director, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

98 Spit Brook Rd Ste 100
NASHUA   NH   03062-5737

Phone: +1603.8825200

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

SPONSORED STORIES